| Description |
1 online resource (360 pages) |
| Series |
Online access: National Academy of Sciences National Academies Press
|
|
Online access: NCBI NCBI Bookshelf
|
| Contents |
Biomedical Politics -- Copyright -- Preface -- Acknowledgments -- Contents -- Introduction -- References -- Unproven AIDS Therapies: The Food and Drug Administration and DDI -- THE DRUG REGULATION PROCESS -- The Drug Approval Process Today -- Speeding Up the Process: The Bush Initiative -- Prelicensing Availability -- PARALLEL TRACK -- PARALLEL TRACK: PROS AND CONS -- The Food and Drug Administration -- The Research Community -- The AIDS Activists -- Other Consumer Interests -- EARLY RELEASE OF DDI -- MOTIVATIONS -- Bristol-Myers |
|
The Food and Drug AdministrationThe National Institutes of Health -- The Activists -- CONCLUSIONS -- NOTES -- REFERENCES -- Commentary -- LEON EISENBERG -- Commentary -- PETER F. CARPENTER -- A Political History of RU-486 -- Introducing Contraceptives to the United States -- THE EARLY DEVELOPMENT OF RU-486 -- COMMERCIAL INTEREST IN RU-486 -- THE GROWING THREAT OF ANTI-ABORTION GROUPS -- CORPORATE PRESSURE FOR WITHDRAWAL -- THE RETURN OF RU-486 -- THE CONTINUING OPPOSITION -- SUCCESS OF THE BOYCOTT THREAT |
|
THE FEMINIST AND MEDICAL COMMUNITY RESPONSEINTERNATIONAL RU-486 AVAILABILITY -- GETTING RU-486 TO THE UNITED STATES -- INDUSTRY CONSTRAINTS ON RU-486 DEVELOPMENT -- Market Share and Price -- FDA Review -- Product Liability -- Public Relations -- AMERICAN ACCESS TO RU-486 IN THE 1990S -- REFERENCES -- Commentary -- WILLIAM N. HUBBARD -- Commentary -- PETER F. CARPENTER -- The Human Genome Project: The Formation of Federal Policies in the United States, 1986�1990 -- TECHNICAL AND SCIENTIFIC BACKGROUND -- ORIGINS OF DEDICATED GENOME RESEARCH PROGRAMS |
|
THE DEPARTMENT OF ENERGY PLANTHE SCIENTIFIC COMMUNITY RESPONDS -- CALLS FOR EVALUATION -- THE NATIONAL INSTITUTES OF HEALTH AND CONGRESS RESPOND -- THE PROJECT IS FUNDED -- SOCIAL ISSUES EMERGE -- STILL, ORGANIZATIONAL ISSUES -- CONCLUSIONS -- APPENDIX A -- Where Was OSTP? -- APPENDIX B -- Can the Genome Project Keep Its Promises? -- APPENDIX C -- Is Cost Wobble a Serious Problem? -- APPENDIX D -- What Is Technically Feasible in the Policy Context? -- REFERENCES -- Commentary -- PAUL BERG -- Commentary -- ERNEST R. MAY |
|
Origins of the Medicare Kidney Disease Entitlement: The Social Security Amendments of 1972A HISTORICAL FOOTNOTE -- ANTECEDENTS TO THE 1972 LEGISLATION -- The Influence of the Gottschalk Report -- Setting the Legislative Stage -- THE SOCIAL SECURITY AMENDMENTS OF 1972, SECTION 299I -- The Legislative Process -- The Policy Context -- The Adoption of Section 299I -- Ways and Means: November and December 1971 -- Senate Finance Committee: 1972 -- The Joint House-Senate Conference Committee: 1972 -- ESTIMATES OF COST -- SUMMARY AND CONCLUSIONS -- AFTERWORD |
| Notes |
""Appendix"" |
|
Print version record |
| Subject |
Medical policy -- Case studies
|
|
Health planning -- Case studies
|
|
Health planning
|
|
Medical policy
|
| Genre/Form |
Case studies
|
| Form |
Electronic book
|
| Author |
Hanna, Kathi E
|
| ISBN |
9780309597579 |
|
0309597579 |
|
9780309044868 |
|
0309044863 |
|
